Alpha 2.0
Login Register
» Authors » Valerie Aponte Ribero

Valerie Aponte Ribero

Explore the profile of Valerie Aponte Ribero including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 30
Followers 0
Related Specialties
Neurology
General Medicine
Health Services
Top 10 Co-Authors
Ksenija Gorni
Cinzia Del Giovane
C Simone Sutherland
Heba Alwan
Nicolas Rodondi
Orestis Efthimiou
Yasmina Marti
Baris Gencer
Laurent Servais
Maryam Oskoui
Published In
J Comp Eff Res
Neurology
Neuromuscul Disord
medRxiv
J Neuromuscul Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
The influence of genotype on the natural history of types 1 - 3 spinal muscular atrophy
Sutherland C, Schneider S, Ribero V, Simpson A, Kokaliaris C, Scalco R, et al.
Neuromuscul Disord . 2025 Jan; 47:105270. PMID: 39864377
The severity of spinal muscular atrophy (SMA) is inversely correlated with the number of survival of motor neuron 2 (SMN2) copies an individual has. This observational, retrospective analysis of natural...
2.
Diabetes and the risk of cardiovascular events and all-cause mortality among older adults: an individual participant data analysis of five prospective studies
Ribero V, Efthimiou O, Abolhassani N, Alwan H, Bauer D, Henrard S, et al.
Eur J Clin Invest . 2024 Oct; 55(2):e14340. PMID: 39465996
Background: Guidelines and studies provide conflicting information on whether type 2 diabetes (T2D) should be considered a coronary heart disease risk (CHD) equivalent in older adults. Methods: We synthesized participant-level...
3.
A Systematic Literature Review of the Natural History of Respiratory, Swallowing, Feeding, and Speech Functions in Spinal Muscular Atrophy (SMA)
Marti Y, Ribero V, Batson S, Mitchell S, Gorni K, Gusset N, et al.
J Neuromuscul Dis . 2024 Jun; 11(5):889-904. PMID: 38943396
Background: Respiratory and bulbar dysfunctions (including swallowing, feeding, and speech functions) are key symptoms of spinal muscular atrophy (SMA), especially in its most severe forms. Demonstrating the long-term efficacy of...
4.
Systematic Literature Review of the Natural History of Spinal Muscular Atrophy: Motor Function, Scoliosis, and Contractures
Ribero V, Marti Y, Batson S, Mitchell S, Gorni K, Gusset N, et al.
Neurology . 2023 Oct; 101(21):e2103-e2113. PMID: 37813581
Background And Objectives: Spinal muscular atrophy (SMA) is a progressive neuromuscular disorder associated with continuous motor function loss and complications, such as scoliosis and contractures. Understanding the natural history of...
5.
A systematic review and meta-analysis investigating the relationship between metabolic syndrome and the incidence of thyroid diseases
Alwan H, Ribero V, Efthimiou O, Del Giovane C, Rodondi N, Duntas L
Endocrine . 2023 Sep; 84(2):320-327. PMID: 37688711
Purpose: To assess the prospective association between metabolic syndrome (MetS), its components, and incidence of thyroid disorders by conducting a systematic review and meta-analysis. Methods: A systematic search was performed...
6.
Cardiovascular disease and type 2 diabetes in older adults: a combined protocol for an individual participant data analysis for risk prediction and a network meta-analysis of novel anti-diabetic drugs
Ribero V, Alwan H, Efthimiou O, Abolhassani N, Bauer D, Henrard S, et al.
medRxiv . 2023 Mar; PMID: 36993427
Introduction: Older and multimorbid adults with type 2 diabetes (T2D) are at high risk of cardiovascular disease (CVD) and chronic kidney disease (CKD). Estimating risk and preventing CVD is a...
7.
How does risdiplam compare with other treatments for Types 1-3 spinal muscular atrophy: a systematic literature review and indirect treatment comparison
Ribero V, Daigl M, Marti Y, Gorni K, Evans R, Scott D, et al.
J Comp Eff Res . 2022 Jan; 11(5):347-370. PMID: 35040693
To conduct indirect treatment comparisons between risdiplam and other approved treatments for spinal muscular atrophy (SMA). Individual patient data from risdiplam trials were compared with aggregated data from published studies...